Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 4, 2026 · most recent call
MRK’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Merck & Co., Inc.’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: MRK daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
No 8-K events recorded since this call day.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Net margin | FCF |
|---|---|---|---|---|---|---|
| FY2024 Q4 | $15.62B | +6.8% | $1.48 | +408.3% | 24.0% | $2.51B |
| FY2025 Q1 | $15.62B | -1.0% | $2.01 | +7.5% | 32.5% | $1.17B |
| FY2025 Q2 | $15.80B | -1.9% | $1.76 | -17.8% | 28.0% | $2.53B |
| FY2025 Q3 | $17.18B | +3.2% | $2.32 | +87.1% | 33.7% | $6.83B |
| FY2025 Q4 | $16.32B | +4.5% | $1.19 | -19.6% | 18.2% | $1.82B |
| FY2026 Q1 | $16.29B | +4.3% | $-1.72 | -185.6% | -26.0% | $2.93B |
| FY2026 Q2Selected | $16.61B | +5.1% | $-0.54 | -130.7% | -8.0% | $4.48B |
Management-stated figures from MRK’s newest call are part of Tellvest Pro.